TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Arecor Therapeutics PLC ( (GB:AREC) ) has issued an announcement.
Arecor Therapeutics has entered into a collaboration with a major global pharmaceutical company to develop a novel formulation of the partner’s proprietary product using Arecor’s Arestat™ technology. This partnership, which is fully funded by the partner, underscores Arecor’s leadership in drug delivery and formulation innovation, potentially leading to future licensing opportunities and enhancing its market positioning.
More about Arecor Therapeutics PLC
Arecor Therapeutics plc is a biopharmaceutical company focused on transforming patient care by enhancing existing therapeutic products. Utilizing its proprietary technology platform, Arestat™, Arecor develops an internal portfolio of products in diabetes and other areas, and collaborates with leading pharmaceutical and biotechnology companies to deliver innovative therapeutic solutions.
YTD Price Performance: -33.33%
Average Trading Volume: 11,996
Technical Sentiment Signal: Buy
Current Market Cap: £18.5M
See more data about AREC stock on TipRanks’ Stock Analysis page.